Stock WOCKPHARMA WOCKHARDT LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Wockhardt Limited

Equities

WOCKPHARMA

INE049B01025

Market Closed - NSE India S.E.
Other stock markets
 07:43:50 2024-04-19 am EDT 		5-day change 1st Jan Change
582.8 INR +1.73% Intraday chart for Wockhardt Limited +1.49% +37.35%
Apr. 03 Wockhardt Limited Announces Cessation of Independent Directors CI
Feb. 14 Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wockhardt Limited Announces Cessation of Independent Directors
CI
Aziwok vs Aziwake: Delhi High Court Grants Interim Injunction In Light Of Rival Marks Being Closely Similar For Azithromycin
AQ
Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Wockhardt Limited Announces Successful Completion of Pivotal Phase 3 Pneumonia Study of Its Macrolide Antibody Nafithromycin WCK 4873
CI
Wockhardt Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
CARE Cuts Rating on Wockhardt's Working Capital to BB+; Outlook Negative
MT
Wockhardt Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Wockhardt Limited Announces Executive Changes
CI
CARE Keeps BBB- Rating on Wockhardt's Bank Financing
MT
Wockhardt Trims Consolidated Loss in Fiscal Q4
MT
Wockhardt Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
INDIA STOCKS-Indian shares fall on rate-hike worries ahead of Fed, RBI minutes
RE
Wockhardt Widens Consolidated Net Profit in Fiscal Q3
MT
Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Wockhardt Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
CARE Keeps Rating on Wockhardt's Long-term Bank Financing, Bonds; Outlook Stable
MT
Wockhardt : Corp Restructuring - others
PU
Wockhardt Starts Global Phase 3 Clinical Study of Novel Antibiotic WCK 5222
MT
Wockhardt Announces Successful Initiation of Global Phase 3 Clinical Study of Its Novel Antibiotic WCK 5222
CI
Wockhardt Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. WOCKPHARMA Stock
  4. News Wockhardt Limited